1. Introduction {#s0005}
===============

Generally, herbal medicines or herbal medicine prescriptions, which consist of two or more herbal medicines, contain many bioactive ingredients that can be effective in various diseases. Despite the increasing interest in herbal medicine prescriptions around the world, many quality assessment methods are still inadequate. Standardization is necessary to ensure constant efficacy and to assess the scientific evidence of today's herbs or formulations. Hyeonggaeyeongyo-tang (HYT), also known as Jing Jie Lian Qiao Tang in Chinese and Keigai-rengyo-to in Japanese, consists of 13 medicinal herbs, Schizonepetae Spica, Forsythiae Fructus, Saposhnikoviae Radix, Angelicae Gigantis Radix, Cnidii Rhizoma, Bupleuri Radix, Aurantii Fructus Immaturus, Scutellariae Radix, Angelicae Dahuricae Radix, Platycodonis Radix, Paeoniae Radix, Gardeniae Fructus, and Glycyrrhizae Radix et Rhizoma, in a 1.4:1.4:1.4:1.4:1.4:1.4:1.4:1.4:1.4:1.4:1.4:1.4:1.0 ratio based on dry weight ([@b0030]). HYT has been recorded in the Joseon Dynasty's *Dongeuibogam* since it was first recorded in *Wanbinghuichun* in the Mying Dynasty ([@b0030], [@b0090]). It has various reported biological effects on, for example, allergic rhinitis, as well as antioxidant, anti-inflammatory, and antimicrobial properties ([@b0080], [@b0085], [@b0090], [@b0035], [@b0050]). The main components of each of the individual herbs forming HYT are: monoterpenoids (e.g., pulegone) from Schizonepetae Spica ([@b0015]), lignans (e.g., arctigenin) from Forsythiae Fructus ([@b0045]), flavonoids (e.g., cimifugin) and polyphenols (e.g., *prim*-*O*-glucosylcimifugin) from Saposhnikoviae Radix ([@b0055]), coumarins (e.g., nodakenin, decursin, and decursinol angelate) from Angelicae Gigantis ([@b0005]), phenylpropanoids (e.g., ferulic acid) from Cnidii Rhizoma ([@b0070]), triterpenoids (e.g., saikosaponin A) from Bupleuri Radix ([@b0025]), flavonoids (e.g., narirutin, naringin, and neohesperidin) from Aurantii Fructus Immaturus ([@b0100]), flavonoids (e.g., baicalin and wogonoside) from Scutellariae Radix ([@b0095]), coumarins (e.g., imperatorin and oxypeucedanin) from Angelicae Dahuricae Radix ([@b0115]), triterpenoids (e.g., platycodin D) from Platycodonis Radix ([@b0020]), monoterpenoids (e.g., paeoniflorin) and phenols (e.g., gallic acid) from Paeoniae Radix ([@b0110]), iridoids (e.g., geniposide) from Gardeniae Fructus ([@b0060]), and triterpenoids (e.g., glycyrrhizin) and flavonoids (e.g., liquiritin apioside and liquiritin) from Glycyrrhizae Radix et Rhizoma ([@b0105]). Recently, [@b0075] reported a pharmacokinetic study of the bioactive flavonoids (apigenin, baicaein, genistein, hesperetin, liquiritigenin, luteolin, nagrigenin, and wogonin) of HYT that showed antibacterial effects on *Staphylococcus aureus* based on analysis by liquid chromatography--mass spectrometry with tandem mass spectrometry (LC--MS/MS). However, this study alone did not provide sufficient data for standardization of the traditional herbal formula, HYT. Therefore, we conducted simultaneous determination of 20 marker components for quality control of HYT based on analysis by high-performance liquid chromatography with photodiode array detection (HPLC--PDA) and by LC--MS/MS; the compounds examined were pulegone (Schizonepetae Spica), arctiin and arctigenin (Forsythiae Fructus), cimifugin (Saposhnikoviae Radix), nodakenin, decursin, and decursinol angelate (Angelicae Gigantis), ferulic acid (Cnidii Rhizoma), narirutin, naringin, and neohesperidin (Aurantii Fructus Immaturus), baicalin, baicalein, wogonin, and wogonoside (Scutellariae Radix), oxypeucedanin hydrate (Angelicae Dahuricae Radix), gallic acid and paeoniflorin (Paeoniae Radix), geniposide (Gardeniae Fructus), and glycyrrhizin (Glycyrrhizae Radix et Rhizoma).

2. Materials and methods {#s0010}
========================

2.1. Plant materials {#s0015}
--------------------

The 13 raw medicinal herbs constituting HYT ([Table 1](#t0005){ref-type="table"}) were purchased from Kwangmyungdang Medicinal Herbs (KMH, Ulsan, Korea) in November 2017. The origin of each herb was confirmed by Dr. Seung-Yeol Oh, president of KMH, based on "The Dispensatory on the Visual and Organoleptic Examination of Herbal Medicine" ([@b0065]). Voucher specimens (2017KE60--1 to 2017KE60--13) have been deposited at the Herbal Medicine Research Division, Korea Institute of Oriental Medicine.Table 1Composition of HYT.Herbal medicineScientific nameFamilyPart usedOriginComposition ratio (%)Schizonepetae Spica*Schizonepeta tenuifolia* BriquetLabiataeSpikeYeongcheon, Korea7.86Forsythiae Fructus*Forsythia viridissima* LindleyOleaceaeFruitUiseong, Korea7.86Saposhnikoviae Radix*Saposhnikovia divaricate* SchischkinUmbelliferaeRootChina7.86Angelicae Gigantis Radix*Angelica gigas* NakaiUmbelliferaeRootPyeongchang, Korea7.86Cnidii Rhizoma*Cnidium officinale* MakinoUmbelliferaeRhizomeYeongyang, Korea7.86Bupleuri Radix*Bupleurum falcatum* LinnéUmbelliferaeRootCheongsong, Korea7.86Aurantii Fructus Immaturus*Citrus aurantium* LinnéRutaceaeFruitChina7.86Scutellariae Radix*Scutellaria baicalensis* GeorgiLabiataeRootYeosu, Korea7.86Angelicae Dahuricae Radix*Angelica dahurica* Bentham et Hooker F.UmbelliferaeRootYeongyang, Korea7.86Platycodonis Radix*Platycodon grandiflorum* A. De CandolleCampanulaceaeRootYeongju, Korea7.86Paeoniae Radix*Paeonia lactiflora* PallasPaeoniaceaeRootUiseong, Korea7.86Gardeniae Fructus*Gardenia jasminoides Ellis*RubiaceaeFruitImsil, Korea7.86Glycyrrhizae Radix et Rhizoma*Glycyrrhiza uralensis Fischer*LeguminosaeRoot and RhizomeChina5.68Total (%)100.00

2.2. Chemicals and reagents {#s0020}
---------------------------

The reference standard components, gallic acid (97.5--102.5%), naringin (95.0%), and baicalein (98.0%) were purchased from Merck KGaA (Darmstadt, Germany); cimifugin (98.0%), nodakenin (99.5%), oxypeucedanin hydrate (98.0%), and wogonin (98.9%) were purchased from ChemFaces Biochemical Co., Ltd. (Wuhan, China); narirutin (99.5%), glycyrrhizin (99.1%), and pulegone (99.3%) were purchased from Biopurify Phytochemicals (Chengdu, China); geniposide (≥98.0%) and baicalin (98.0%) were purchased from Wako Chemicals (Osaka, Japan); paeoniflorin (99.4%), ferulic acid (98.0%), neohesperidin (98.4%), arctiin (98.1%), wogonoside (98.9%), and arctigenin (99.4%) were purchased from Shanghai Sunny Biotech (Shanghai, China); and decursin (98.0%) and decursinol angelate (98.0%) were purchased from NPC Bio Technology (Yeongi, Korea). The chemical structures of these reference compounds are shown [Fig. 1](#f0005){ref-type="fig"}. HPLC-grade solvents (methanol, acetonitrile, and water) and ACS reagent-grade formic acid (≥98.0%) for test solution preparation and simultaneous analysis were purchased from J. T. Baker (Phillipsburg, NJ, USA) and Merck KGaA (Darmstadt, Germany), respectively.Fig. 1Chemical structures of the 20 biomarker components in HYT.

2.3. Preparation of HYT water extract {#s0025}
-------------------------------------

The 13 crude herbs, Schizonepetae Spica, Forsythiae Fructus, Saposhnikoviae Radix, Angelicae Gigantis Radix, Cnidii Rhizoma, Bupleuri Radix, Aurantii Fructus Immaturus, Scutellariae Radix, Angelicae Dahuricae Radix, Platycodonis Radix, Paeoniae Radix, Gardeniae Fructus (393.24 g each), and Glycyrrhizae Radix et Rhizoma (281.12 g) constituting HYT were mixed and extracted in water for 2 h at 100 °C under pressure (98 kPa) using an electric extractor (COSMOS-660; Kyungseo Machine Co., Incheon, Korea). The extracted solution was filtered and freeze-dried to give a powder sample. The amount of extracted HYT was 1296.4 g (25.9%).

2.4. Preparation of samples and standard solutions {#s0030}
--------------------------------------------------

To simultaneously analyse the 20 biomarker components ([Fig. 1](#f0005){ref-type="fig"}) in HYT extract, 100.0 mg of freeze-dried HYT sample was added to a 10 mL volumetric flask and 70% methanol was added. Ultrasonic extraction was then performed for 60 min at room temperature with a Branson 8510 ultrasonicator (Denbury, CT, USA). After extraction, the solution was filtered through a 0.2 μm GHP membrane filter (PALL Life Sciences, Ann Arbor, MI, USA) before HPLC injection. Standard solutions of the 20 reference standard analytes were prepared at a concentration of 1000.0 μg/mL using methanol, and each prepared stock solution was stored in a refrigerator until use.

2.5. HPLC--PDA equipment and conditions used for analysis of the 20 marker components {#s0035}
-------------------------------------------------------------------------------------

The HPLC system used for simultaneous analysis of the 20 biomarker constituents in HYT was a Shimadzu Prominence LC-20A series HPLC system (Kyoto, Japan) with a two pumps (LC-20AT), online degasser (DGU-20A~3~), a forced air circulation type column oven (CTO-20A), automatic sample injector (SIL-20A), and PDA detector (SPD-M20A). All chromatographic signals were acquired and processed with LabSolution software (Version 5.53, SP3, Kyoto, Japan). A reverse-phase SunFire^TM^ C~18~ analytical column (4.6 × 250 mm, 5 μm; Waters, Torrance, CA, USA) maintained at 40 °C was used for chromatographic separation. For efficient separation of all marker components, a gradient of 0.1% (v/v) aqueous formic acid (A) and acetonitrile with 0.1% (v/v) formic acid (B), was used: 0--50 min, 5--60% B; 50--60 min, 60--100% B; 60--70 min, 100% B; 70--80 min, 100--5% B. The flow rate of the mobile phase was 1.0 mL/min, and 10 μL of standard or test solution was injected.

2.6. LC--MS/MS apparatus and conditions for analysis of the 20 marker components {#s0040}
--------------------------------------------------------------------------------

LC--MS/MS analysis of the 20 marker components in HYT was conducted with a Waters ACQUITY UPLC H-Class system (Milford, MA, USA) with a Xevo TQ-S micro triple quadrupole mass spectrometer (Milford) and ESI source. LC--MS/MS analysis of the 20 analytes was conducted with a Waters ACQUITY UPLC BEH C~18~ column (2.1 × 100 mm, 1.7 μm) (Milford) maintained at 40 °C. Water with 0.1% (v/v) formic acid (A) and acetonitrile (B) were used as mobile phases with a gradient of 10% B (initial--1.0 min), 10--40% B (1.0--6.0 min), 40--95% B (6.0--10.0 min), 95% B (100--15.0 min), 95--10% B (15.0--15.1 min), and 10% B (15.1--18.0 min). The flow rate was 0.3 mL/min and injection volume of 2.0 μL were used. Samples were maintained at 5 °C. MS detection was conducted with a positive and negative ion ESI--MS/MS in the multiple reaction monitoring (MRM) mode. The optimized analytical parameters, collision energy, cone voltage, and transition, for MS/MS MRM analysis are summarized in [Table 1S](#s0095){ref-type="sec"}. Other MS parameters were as follows: capillary voltage, 1.2 kV; source temperature, 150 °C; desolvation temperature, 450 °C; desolvation gas flow, 800 L/h; and cone gas flow, 50 L/h. All data were acquired and processed with Waters MassLynx software version 4.2 (Milford).

2.7. Analytical method validation {#s0045}
---------------------------------

The analytical method was validated with respect to linearity, limit of detection (LOD), limit of quantification (LOQ), accuracy, intraday and interday precision, and repeatability according to the International Conference on Harmonisation (ICH) guidance for Q2B validation of analytical procedures ([@b0040]). Namely, linearity was evaluated by the coefficient of determination (*r*^2^) of the calibration curve in the tested linear range of each compound. LOD and LOQ values were calculated as LOD = 3.3 × *σ*/*S* and LOQ = 10 × *σ*/*S*, based on the standard deviation of the *y*-intercept in each calibration curve (*σ*) and the slope of the calibration curve (*S*). Accuracy, tested as percentage recovery, was determined by using the standard addition method and calculated as Recovery (%) = (founded concentration -- original concentration) / spiked concentration × 100. Intraday precision was determined by analyzing a single sample five times within a day and interday precision was determined by measuring the sample on three consecutive days. Repeatability was measured six times using a standard solution. These parameters, intraday and interday precision, and repeatability, were evaluated by calculating the relative standard deviation (RSD) and calculated by the following equation. RSD (%) = standard deviation (SD) / mean × 100. To assess the effectiveness of the HPLC analytical method, the system suitability parameters capacity factor (*k′*), selectivity factor (*α*), resolution (*Rs*), number of theoretical plates (*N*), and tailing factor (*Tf*) were calculated ([@b0010]).

3. Results and discussion {#s0050}
=========================

3.1. Optimization of chromatographic conditions {#s0055}
-----------------------------------------------

A range of HPLC analysis conditions including column types (e.g., SunFire C~18~, Gemini C~18~, Capcellpak UG120 C~18~, and OptimaPak C~18~ columns), column temperatures (e.g., 30, 35, 40, and 45 °C), and mobile phases (e.g., formic acid with distilled water and acetonitrile) were applied to separate the 20 marker compounds ([Fig. 1](#f0005){ref-type="fig"}) from a standard solution of HYT, and the separation efficiency of the conditions were assessed. Optimum HPLC analytical conditions were established in which all 20 marker components were efficiently separated with a resolution greater than 1.5 within 60 min using a SunFire C~18~ column (250 mm × 4.6 mm, 5 μm), a column temperature of 40 °C, and mobile phase system of distilled water--acetonitrile, both containing formic acid, as described in [Section 2.5](#s0035){ref-type="sec"}.

3.2. Method validation {#s0060}
----------------------

### 3.2.1. HPLC analysis {#s0065}

System suitability parameters were calculated to characterize the assay for the analysis of the 20 marker components of HYT. The parameters *k′*, *α*, *N*, *Rs,* and *Tf* of the 20 marker components in the established HPLC analytical method were 1.20--18.37, 1.01--3.47, 2124.64--263946.70, 1.59--33.70, and 1.00--1.20, respectively ([Table 2S](#s0095){ref-type="sec"}). All calibration data, namely, the calibration equation, range, *r*^2^, LOD, and LOQ are presented in [Table 4](#t0020){ref-type="table"} and the data showed good linearity with *r*^2^ ≥ 0.9999 over the tested concentration range. The LOD and LOQ values of all marker compounds were determined in the concentration range 0.09--0.69 μg/mL and 0.28--2.09 μg/mL, respectively ([Table 2](#t0010){ref-type="table"}). The recovery measured for of all marker components at three concentration levels ranged from 93.92 to 102.66%, and RSD values were below 3.00% ([Table 3](#t0015){ref-type="table"}). Furthermore, as shown in [Table 4](#t0020){ref-type="table"}, good RSD values of ≤ 3.44% were measured for the intraday, interday, and repeatability measurements that established the precision. These results demonstrate that the optimized HPLC analytical method is suitable for simultaneous determination of the 20 marker components in HYT.Table 2Linear range, calibration curve, *r*^2^, LODs, and LOQs for marker compounds (*n* = 3) obtained by HPLC analysis.CompoundLinear range (μg/mL)SlopeIntercept*r*^2^LOD[a](#tblfn1){ref-type="table-fn"}\
(μg/mL)LOQ[b](#tblfn2){ref-type="table-fn"}\
(μg/mL)Gallic acid0.78--50.0035948.04--6660.810.99990.040.13Cimifugin0.78--50.0039219.86619.911.00000.100.32Geniposide1.56--100.0024983.5612795.820.99990.331.01Paeoniflorin1.56--100.0016644.46--471.601.00000.130.40Ferulic acid0.78--50.0080306.6117771.760.99990.180.55Nodakenin0.78--50.0034392.557850.450.99990.200.61Narirutin0.78--50.0017712.022844.500.99990.170.51Naringin3.13--200.0018401.3912604.610.99990.431.29Neohesperidin1.56--100.0022196.837453.750.99990.280.86Arctiin0.78--50.006160.87895.990.99990.110.33Baicalin3.13--200.0040000.3516407.750.99990.692.09Oxypeucedanin hydrate0.78--50.0032886.818226.870.99990.180.53Wogonoside3.13--200.0049151.4028419.520.99990.581.77Baicalein0.78--50.0061272.42--5827.911.00000.090.28Arctigenin0.78--50.0010745.951493.810.99990.140.41Glycyrrhizin3.13--200.009021.587572.140.99990.601.81Wogonin0.78--50.0089117.3610775.130.99990.140.42Pulegone0.78--50.0020965.364642.950.99990.190.57Decursin0.78--50.0040716.0713179.770.99990.170.52Decursinol angelate0.78--50.0026680.957563.470.99990.170.52[^1][^2]Table 3Recovery test for the assay of the 20 components in HYT using HPLC.CompoundOriginal conc. (μg/mL)Spiked conc. (μg/mL)Found conc. (μg/mL)Recovery (%)[a](#tblfn3){ref-type="table-fn"}SDRSD (%)Gallic acid6.591.007.5899.001.641.662.008.5396.970.750.784.0010.5398.451.411.43Cimifugin7.602.009.5094.790.460.484.0011.5498.351.001.018.0015.3897.210.490.51Geniposide29.346.0035.3299.631.211.2215.0044.2599.350.460.4630.0058.4196.890.140.15Paeoniflorin27.826.0033.7598.882.042.0715.0042.7499.491.301.3130.0058.32101.690.340.34Ferulic acid3.351.004.3397.901.241.262.005.2595.101.111.164.007.2196.410.510.53Nodakenin10.052.0011.9896.111.071.115.0014.9798.220.400.4110.0019.5294.670.971.02Narirutin9.802.0011.7597.431.411.455.0014.7598.981.581.6010.0019.7899.741.081.08Naringin41.248.0049.2499.990.950.9520.0060.7697.590.390.4040.0081.88101.600.840.83Neohesperidin28.676.0034.4596.250.840.8715.0042.8194.230.390.4230.0057.0994.730.380.40Arctiin10.772.0012.7699.492.152.175.0015.83101.201.041.0210.0020.6598.721.221.23Baicalin70.6414.0084.79101.050.570.5635.00104.6497.130.420.4370.00137.8295.960.810.84Oxypeucedanin hydrate4.431.005.3894.700.790.832.006.3595.741.311.374.008.1993.920.670.72Wogonoside39.828.0047.6898.251.651.6820.0058.9695.720.760.8040.0077.7294.760.750.80Baicalein12.892.0014.8899.422.232.244.0016.8298.142.452.498.0020.8799.691.641.64Arctigenin8.362.0010.3498.871.321.344.0012.36100.011.231.238.0016.1697.571.781.83Glycyrrhizin37.228.0045.0798.242.802.8520.0057.27100.282.332.3340.0076.1697.370.640.65Wogonin1.761.002.7396.971.231.272.003.7498.682.422.454.005.6597.231.271.31Pulegone2.821.003.8098.152.822.872.004.8098.681.631.654.006.6395.281.591.67Decursin2.541.003.54100.050.910.912.004.4896.670.860.894.006.4697.820.230.24Decursinol angelate2.131.003.1298.780.620.622.004.19102.661.681.644.006.1399.810.500.50[^3]Table 4Precision assay for the 20 marker compounds in HYT by HPLC.CompoundConc. (μg/mL)Intraday (n = 5)Interday (n = 5)Repeatability (n = 6)Observed conc. (μg/mL)Precision (%)[a](#tblfn4){ref-type="table-fn"}Accuracy (%)Observed conc. (μg/mL)Precision (%)Accuracy (%)RSD (%) of retention timeRSD (%) of peak areaGallic acid12.512.190.040.3197.5212.180.170.040.2125.024.280.100.4097.1324.350.4650.049.000.180.3797.9949.150.43Cimifugin12.512.470.151.2299.7812.580.380.020.3825.024.970.251.0299.8824.950.3550.050.520.821.62101.0450.430.88Geniposide25.024.200.421.7596.8224.510.810.010.2250.048.410.671.3896.8148.210.89100.097.092.062.1297.0996.792.05Paeoniflorin25.024.330.401.6397.3324.340.560.010.5150.050.010.741.48100.0149.861.15100.0100.480.350.35100.48100.341.36Ferulic acid12.512.060.201.6796.4812.200.390.020.2525.024.120.331.3796.4924.040.4350.048.541.012.0897.0948.431.04Nodakenin12.512.060.211.7496.4412.210.420.020.2425.024.120.331.3796.4824.030.4550.048.511.032.1297.0348.371.04Narirutin12.512.050.070.5596.3912.010.080.020.2425.023.980.150.6595.9324.100.5650.047.710.200.4195.4347.780.31Naringin50.048.250.290.6096.5148.100.310.020.26100.096.070.610.6496.0796.381.64200.0191.140.820.4395.57191.391.29Neohesperidin25.024.120.140.5996.4724.040.150.020.2950.048.000.280.5896.0047.940.40100.095.510.360.3895.5195.640.61Arctiin12.512.120.080.6596.9312.120.080.020.2825.024.130.130.5296.5324.130.2250.047.980.160.3495.9548.110.26Baicalin50.048.250.250.5296.5148.100.270.020.29100.096.120.480.5096.1295.990.83200.0191.540.630.3395.77191.801.23Oxypeucedanin hydrate12.512.030.171.3896.2712.140.290.010.2725.024.160.341.4196.6324.070.4450.048.481.032.1296.9648.381.04Wogonoside50.048.220.310.6596.4348.070.290.010.33100.096.290.540.5696.2996.140.83200.0191.380.680.3695.69191.651.27Baicalein12.512.120.070.5896.9712.100.120.010.2425.024.230.080.3396.9324.190.2850.048.390.140.2896.7848.470.36Arctigenin12.512.110.100.8596.9012.070.130.010.2925.024.050.190.7996.2124.020.2550.047.850.220.4595.7147.880.34Glycyrrhizin50.048.380.881.8296.7648.971.610.010.29100.096.641.441.4996.6496.321.76200.0194.314.222.1797.16193.514.16Wogonin12.512.030.080.6596.2712.000.080.010.4525.023.990.140.5995.9723.930.2350.047.600.210.4495.2047.780.35Pulegone12.512.140.181.4597.1412.160.190.010.2225.024.290.301.2497.1724.150.4150.048.380.711.4696.7748.320.81Decursin12.512.070.201.6696.5512.170.290.010.3125.024.130.331.3696.5124.050.4350.048.430.941.9596.8648.330.97Decursinol angelate12.512.060.211.7296.5012.150.280.010.2825.024.110.341.4196.4424.050.4250.048.410.972.0196.8348.320.97[^4]

### 3.2.2. LC--MS/MS analysis {#s0070}

As shown in [Table 1S](#s0095){ref-type="sec"} and [Fig. 1S](#s0095){ref-type="sec"}, six components, gallic acid, geniposide, paeoniflorin, narirutin, naringin, and glycyrrhizin, were detected in the negative ion mode \[M − H\]^−^ at *m*/*z* 169.30, 387.34, 479.17, 579.26, 579.45, and 821.56, respectively, whereas thirteen analytes, ferulic acid, cimifugin, nodakenin, neohesperidin, baicalin, oxypeucedanin hydrate, wogonoside, baicalein, arctigenin, wogonin, pulegone, decursin, and decursinol angelate, were detected in the positive ion mode \[M + H\]^+^ at *m*/*z* 195.04, 307.19, 409.19, 611.26, 447.25, 305.23, 461.15, 271.17, 373.22, 285.14, 153.30, 329.19, and 329.19, respectively. Arctiin was detected at *m*/*z* 557.22 in the form of \[M + Na\]^+^ in positive ion mode. The calibration curves of all the analytes had a coefficient of determination of more than 0.99, thus showing good linearity within the tested concentration range. The LOD and LOQ values of these compounds were calculated to be 0.09--0.69 μg/mL and 0.28--2.09 μg/mL based on signal-to-noise ratios of 3.3 and 10, respectively. The analytical parameters, calibration curve data, LOD, and LOQ, for quantitative analysis of each component are summarized in [Table 3S](#s0095){ref-type="sec"}.

3.3. Simultaneous determination of the 20 marker components in HYT samples by using HPLC--PDA {#s0075}
---------------------------------------------------------------------------------------------

The established analytical method using HPLC--PDA was successfully applied for the simultaneous quantification of the 20 marker analytes ([Fig. 1](#f0005){ref-type="fig"}) for quality assessment of HYT samples. Samples were measured in triplicate for each batch. The origin of the peak corresponding to each analytic component was confirmed by comparing the UV spectrum and the retention time with those of the reference standard. Representative HPLC--PDA chromatograms of standard solutions and a HYT sample are shown in [Fig. 2](#f0010){ref-type="fig"}; all analytes eluted within 60 min. The assays revealed that the 20 marker analytes were found in the samples at 0.18--14.60 mg/freeze-dried g ([Table 5](#t0025){ref-type="table"}).Fig. 2HPLC chromatograms of the standard solutions (A) and HYT sample (B) at 230 nm (I), 240 nm (II), 254 nm (III), 270 nm (IV), 275 nm (V), 280 nm (VI), 310 nm (VII), 320 nm (VIII), 325 nm (IX), 330 nm (X), and 335 nm (XI). Gallic acid (**1**), cimifugin (**2**), geniposide (**3**), paeoniflorin (**4**), ferulic acid (**5**), nodakenin (**6**), narirutin (**7**), naringin (**8**), neohesperidin (**9**), arctiin (**10**), baicalin (**11**), oxypeucedanin hydrate (**12**), wogonoside (**13**), baicalein (**14**), arctigenin (**15**), glycyrrhizin (**16**), wogonin (**17**), pulegone (**18**), decursin (**19**), and decursinol angelate (**20**).Table 5Amounts of the 20 marker components in the HYT using HPLC--PDA (n = 3).CompoundBatch No.123Mean (mg/g)\
±SD (×10^--2^)RSD (%)Mean (mg/g)\
±SD (×10^--2^)RSD (%)Mean (mg/g)\
±SD (×10^--2^)RSD (%)Gallic acid0.66 ± 1.031.560.66 ± 0.270.410.66 ± 0.330.50Cimifugin0.78 ± 1.852.360.78 ± 1.742.240.78 ± 1.131.45Geniposide6.13 ± 6.000.986.11 ± 0.740.126.10 ± 1.810.30Paeoniflorin3.17 ± 3.040.963.13 ± 6.492.073.17 ± 0.170.05Ferulic acid0.34 ± 0.431.290.34 ± 0.180.550.33 ± 0.050.15Nodakenin1.06 ± 0.940.891.04 ± 0.750.721.05 ± 0.400.39Narirutin1.00 ± 0.560.560.98 ± 0.750.770.99 ± 1.031.04Naringin8.27 ± 6.830.838.23 ± 2.410.298.22 ± 2.670.32Neohesperidin5.83 ± 4.080.705.84 ± 7.151.235.80 ± 1.760.30Arctiin1.21 ± 0.990.821.16 ± 1.451.251.21 ± 1.991.64Baicalin14.60 ± 14.641.0014.56 ± 5.500.3814.52 ± 4.870.34Oxypeucedanin hydrate0.43 ± 0.250.590.43 ± 0.841.970.42 ± 0.130.31Wogonoside4.04 ± 4.041.004.01 ± 0.620.154.01 ± 0.730.18Baicalein0.78 ± 1.101.410.78 ± 1.241.600.76 ± 1.221.60Arctigenin0.80 ± 0.410.520.79 ± 0.470.590.80 ± 0.420.53Glycyrrhizin3.76 ± 0.900.243.72 ± 3.811.033.76 ± 1.340.36Wogonin0.18 ± 0.090.480.18 ± 0.030.140.18 ± 0.020.10Pulegone0.28 ± 0.170.600.28 ± 0.180.630.28 ± 0.120.43Decursin0.25 ± 0.050.200.25 ± 0.190.760.25 ± 0.311.24Decursinol angelate0.21 ± 0.080.360.21 ± 0.070.340.21 ± 0.210.98

3.4. Simultaneous determination of the 20 marker components in HYT samples using LC--MS/MS {#s0080}
------------------------------------------------------------------------------------------

The 20 marker components in HYT were analyzed and quantified using the optimized LC--MS/MS assays. Quantification of all analytes was conducted by using the MRM method in both positive and negative ion modes. The 20 components, gallic acid, geniposide, paeoniflorin, ferulic acid, cimifugin, nodakenin, narirutin, naringin, neohesperidin, arctiin, baicalin, oxypeucedanin hydrate, wogonoside, baicalein, arctigenin, glycyrrhizin, wogonin, pulegone, decursin, and decursinol angelate, were detected at 1.04, 3.59, 4.22, 4.65, 5.02, 5.03, 5.12, 5.30, 5.61, 5.78, 6.45, 6.58, 6.68, 7.84, 8.10, 8.19, 8.72, 9.38, 9.91, and 9.96 min, respectively ([Fig. 3](#f0015){ref-type="fig"}), and the amounts of these analytes in the samples were determined to be 0.01--1.76 mg/lyophilized g ([Table 6](#t0030){ref-type="table"}).Fig. 3Total ion chromatograms of the reference standard (A) and HYT sample (B) by LC--MS/MS MRM mode. Gallic acid (**1**), geniposide (**2**), paeoniflorin (**3**), ferulic acid (**4**), cimifugin (**5**), nodakenin (**6**), narirutin (**7**), naringin (**8**), neohesperidin (**9**), baicalin (**10**), arctiin (**11**), oxypeucedanin hydrate (**12**), wogonoside (**13**), baicalein (**14**), glycyrrhizin (**15**), arctigenin (**16**), wogonin (**17**), pulegone (**18**), decursin (**19**), and decursinol angelate (**20**).Table 6The amount of 20 marker components in the HYT using LC--MS/MS (n = 3).CompoundAmount (mg/g)MeanSD (×10^--2^)RSD (%)Gallic acid0.110.363.39Cimifugin0.010.010.92Geniposide0.973.873.97Paeoniflorin0.472.204.65Ferulic acid0.030.093.25Nodakenin0.120.816.79Narirutin0.050.132.74Naringin0.670.881.30Neohesperidin0.614.006.56Baicalin1.764.712.67Arctiin0.050.142.89Oxypeucedanin hydrate0.040.194.28Wogonoside0.443.768.50Baicalein0.140.574.20Arctigenin0.100.373.81Glycyrrhizin0.440.751.70Wogonin0.030.113.23Pulegone0.040.266.12Decursin0.040.061.39Decursinol angelate0.110.625.71

4. Conclusion {#s0085}
=============

We have described the first quantitative analysis of 20 marker components of the oriental herbal prescription HYT by using a simple and convenient HPLC--PDA method and a more sensitive and selective LC--MS/MS MRM method. As a result of the analysis of all the marker analytes under the optimized analytical conditions, baicalin, the main ingredient of Scutellariae Radix, was found to be most abundant at 14.60 and 1.76 mg/freeze-dried g based on the HPLC--PDA method and LC--MS/MS method, respectively. These HPLC--PDA and LC--MS methods are expected to be effective for quality evaluation of HYT and other related herbal formulas.
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[^1]: LOD = 3.3 × *σ*/*S*.

[^2]: LOQ = 10 × *σ*/*S*.

[^3]: Recovery (%) = (Found conc. -- Original conc.) / Spiked conc. × 100.

[^4]: Precision is expressed as RSD (%) = (SD / mean) × 100.
